If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 53 Similar Profiles
Graft vs Host Disease Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Transplants Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Bone Marrow Transplantation Medicine & Life Sciences
Unrelated Donors Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Homologous Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2001 2024

BMT Outcomes

Weisdorf, D. J. & El Jurdi, N.

Incyte Corporation

11/20/1911/20/20

Project: Research project

Incyte Research Consulting

Weisdorf, D. J.

Incyte Corporation

9/26/199/25/20

Project: Research project

Consulting

Research Output 1976 2020

Graft vs Host Disease
Steroids
Pediatrics
Phenotype
Unrelated Donors

Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy

Rashidi, A., Kaiser, T., Graiziger, C., Holtan, S. G., Rehman, T. U., Weisdorf, D. J., Khoruts, A. & Staley, C., Jan 1 2020, In : Leukemia. 34, 1, p. 312-316 5 p.

Research output: Contribution to journalLetter

Fever
Drug Therapy
Infection
Gastrointestinal Microbiome
6 Citations (Scopus)

Adaptive NK cell reconstitution is associated with better clinical outcomes

Cichocki, F., Taras, E., Chiuppesi, F., Wagner, J. E., Blazar, B. R., Brunstein, C., Luo, X., Diamond, D. J., Cooley, S., Weisdorf, D. J. & Miller, J. S., Jan 24 2019, In : JCI Insight. 4, 2, Y.

Research output: Contribution to journalArticle

Open Access
Natural Killer Cells
Cytomegalovirus
Transplants
Hematologic Neoplasms
Hematopoietic Stem Cells
3 Citations (Scopus)

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Ustun, C., Le-Rademacher, J., Wang, H. L., Othus, M., Sun, Z., Major, B., Zhang, M. J., Storrick, E., Lafky, J. M., Chow, S., Mrózek, K., Attar, E. C., Nand, S., Bloomfield, C. D., Cripe, L. D., Tallman, M. S., Appelbaum, F., Larson, R. A., Marcucci, G., Roboz, G. J. & 12 others, Uy, G. L., Stone, R. M., Jatoi, A., Shea, T. C., de Lima, M., Foran, J. M., Sandmaier, B. M., Litzow, M. R., Erba, H. P., Hurria, A., Weisdorf, D. J. & Artz, A. S., Nov 1 2019, In : Leukemia. 33, 11, p. 2599-2609 11 p.

Research output: Contribution to journalArticle

Open Access
Consolidation Chemotherapy
Cell Transplantation
Acute Myeloid Leukemia
Drug Therapy
Survival
1 Citation (Scopus)
Graft vs Host Disease
Ulcerative Colitis
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Colitis